{"filing":{"accession_number":"0001193125-26-261658","cik":"0001382101","ticker":"STRO","company_name":"SUTRO BIOPHARMA, INC.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"d116098d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1382101/000119312526261658/d116098d8k.htm"},"events":[{"id":6186,"run_id":5432,"accession_number":"0001193125-26-261658","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the June 5, 2026 Annual Meeting of Stockholders, reporting the outcomes of three proposals: election of three Class II directors (Jane Chung, Connie Matsui, and James Panek), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated voting results with shares for, against, withheld, and abstaining are the hallmark of Item 5.07 disclosure and constitute material information about corporate governance actions.","company_name":"SUTRO BIOPHARMA, INC.","ticker":"STRO","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5146,"accession_number":"0001193125-26-261658","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the June 5, 2026 Annual Meeting of Stockholders, reporting the outcomes of three proposals: election of three Class II directors (Jane Chung, Connie Matsui, and James Panek), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated voting results with shares for, against, withheld, and abstaining are the hallmark of Item 5.07 disclosure and constitute material information about corporate governance actions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:02:13.250372+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5146,"accession_number":"0001193125-26-261658","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the June 5, 2026 Annual Meeting of Stockholders, reporting the outcomes of three proposals: election of three Class II directors (Jane Chung, Connie Matsui, and James Panek), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated voting results with shares for, against, withheld, and abstaining are the hallmark of Item 5.07 disclosure and constitute material information about corporate governance actions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:02:13.250372+00:00","company_name":"SUTRO BIOPHARMA, INC.","ticker":"STRO","filing_date":"2026-06-08"}]}